Levy Guy

Track

Insider profile

Performance

Overall performance
2.3
Performance over holding periods
2.3
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Levy Guy's trades of Parabilis Medicines Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Bioatla Inc (BCAB)
Transaction date
Sale
Price
200.62
Quantity 78,730 +14.7%
Value US$23,676
US Bioatla Inc (BCAB)
Transaction date
Sale
Price
39.16
Quantity 337,220 -18.8%
Value US$13,205,535
US Bioatla Inc (BCAB)
Transaction date
Purchase
Price
18.00
Quantity 333,333 +inf%
Value US$5,999,994
US Bioatla Inc (BCAB)
Transaction date
Purchase
Price
18.00
Quantity 1,055,557 +inf%
Value US$19,000,026
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-29 2026-06-11
B Purchase
68,753 +45.2%
45.55
US$4,143,763 		68,753 +45.2% 45.55 US$4,143,763
2026-06-29 2026-06-11
B Purchase
69,026 +32.9%
31.37
US$1,838,794 		69,026 +32.9% 31.37 US$1,838,794
2021-06-21 2021-06-17
US Bioatla Inc (BCAB)
S Sale
78,730 +14.7%
200.62
US$23,676 		78,730 +14.7% 200.62 US$23,676
2021-06-21 2021-06-17
US Bioatla Inc (BCAB)
S Sale
337,220 -18.8%
39.16
US$13,205,535 		337,220 -18.8% 39.16 US$13,205,535
2020-12-22 2020-12-18
US Bioatla Inc (BCAB)
B Purchase
333,333 +inf%
18.00
US$5,999,994 		333,333 +inf% 18.00 US$5,999,994
2020-12-22 2020-12-18
US Bioatla Inc (BCAB)
B Purchase
1,055,557 +inf%
18.00
US$19,000,026 		1,055,557 +inf% 18.00 US$19,000,026